Copyright Reports & Markets. All rights reserved.

Global Hydroxyprogesterone Caproate Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hydroxyprogesterone Caproate Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 1 mL Injection(Including 1.1 mL)
    • 1.3.3 5 mL Injection
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Hydroxyprogesterone Caproate Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals Injection
    • 1.4.3 Clinics Injection
  • 1.5 Global Hydroxyprogesterone Caproate Injection Market Size & Forecast
    • 1.5.1 Global Hydroxyprogesterone Caproate Injection Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Hydroxyprogesterone Caproate Injection Sales Quantity (2019-2030)
    • 1.5.3 Global Hydroxyprogesterone Caproate Injection Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 AMAG Pharmaceuticals
    • 2.1.1 AMAG Pharmaceuticals Details
    • 2.1.2 AMAG Pharmaceuticals Major Business
    • 2.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product and Services
    • 2.1.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 AMAG Pharmaceuticals Recent Developments/Updates
  • 2.2 Mcguff Pharmaceuticals Inc
    • 2.2.1 Mcguff Pharmaceuticals Inc Details
    • 2.2.2 Mcguff Pharmaceuticals Inc Major Business
    • 2.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product and Services
    • 2.2.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Mcguff Pharmaceuticals Inc Recent Developments/Updates
  • 2.3 Aspen Oss B.V
    • 2.3.1 Aspen Oss B.V Details
    • 2.3.2 Aspen Oss B.V Major Business
    • 2.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product and Services
    • 2.3.4 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Aspen Oss B.V Recent Developments/Updates
  • 2.4 American Regent, Inc.
    • 2.4.1 American Regent, Inc. Details
    • 2.4.2 American Regent, Inc. Major Business
    • 2.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Product and Services
    • 2.4.4 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 American Regent, Inc. Recent Developments/Updates
  • 2.5 Mylan Institutional
    • 2.5.1 Mylan Institutional Details
    • 2.5.2 Mylan Institutional Major Business
    • 2.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Product and Services
    • 2.5.4 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Mylan Institutional Recent Developments/Updates

3 Competitive Environment: Hydroxyprogesterone Caproate Injection by Manufacturer

  • 3.1 Global Hydroxyprogesterone Caproate Injection Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Hydroxyprogesterone Caproate Injection Revenue by Manufacturer (2019-2024)
  • 3.3 Global Hydroxyprogesterone Caproate Injection Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Hydroxyprogesterone Caproate Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Hydroxyprogesterone Caproate Injection Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Hydroxyprogesterone Caproate Injection Manufacturer Market Share in 2023
  • 3.5 Hydroxyprogesterone Caproate Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Hydroxyprogesterone Caproate Injection Market: Region Footprint
    • 3.5.2 Hydroxyprogesterone Caproate Injection Market: Company Product Type Footprint
    • 3.5.3 Hydroxyprogesterone Caproate Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hydroxyprogesterone Caproate Injection Market Size by Region
    • 4.1.1 Global Hydroxyprogesterone Caproate Injection Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Hydroxyprogesterone Caproate Injection Consumption Value by Region (2019-2030)
    • 4.1.3 Global Hydroxyprogesterone Caproate Injection Average Price by Region (2019-2030)
  • 4.2 North America Hydroxyprogesterone Caproate Injection Consumption Value (2019-2030)
  • 4.3 Europe Hydroxyprogesterone Caproate Injection Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Hydroxyprogesterone Caproate Injection Consumption Value (2019-2030)
  • 4.5 South America Hydroxyprogesterone Caproate Injection Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Hydroxyprogesterone Caproate Injection Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Hydroxyprogesterone Caproate Injection Sales Quantity by Type (2019-2030)
  • 5.2 Global Hydroxyprogesterone Caproate Injection Consumption Value by Type (2019-2030)
  • 5.3 Global Hydroxyprogesterone Caproate Injection Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Hydroxyprogesterone Caproate Injection Sales Quantity by Application (2019-2030)
  • 6.2 Global Hydroxyprogesterone Caproate Injection Consumption Value by Application (2019-2030)
  • 6.3 Global Hydroxyprogesterone Caproate Injection Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Hydroxyprogesterone Caproate Injection Sales Quantity by Type (2019-2030)
  • 7.2 North America Hydroxyprogesterone Caproate Injection Sales Quantity by Application (2019-2030)
  • 7.3 North America Hydroxyprogesterone Caproate Injection Market Size by Country
    • 7.3.1 North America Hydroxyprogesterone Caproate Injection Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Hydroxyprogesterone Caproate Injection Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Hydroxyprogesterone Caproate Injection Sales Quantity by Type (2019-2030)
  • 8.2 Europe Hydroxyprogesterone Caproate Injection Sales Quantity by Application (2019-2030)
  • 8.3 Europe Hydroxyprogesterone Caproate Injection Market Size by Country
    • 8.3.1 Europe Hydroxyprogesterone Caproate Injection Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Hydroxyprogesterone Caproate Injection Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Hydroxyprogesterone Caproate Injection Market Size by Region
    • 9.3.1 Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Hydroxyprogesterone Caproate Injection Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Hydroxyprogesterone Caproate Injection Sales Quantity by Type (2019-2030)
  • 10.2 South America Hydroxyprogesterone Caproate Injection Sales Quantity by Application (2019-2030)
  • 10.3 South America Hydroxyprogesterone Caproate Injection Market Size by Country
    • 10.3.1 South America Hydroxyprogesterone Caproate Injection Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Hydroxyprogesterone Caproate Injection Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Hydroxyprogesterone Caproate Injection Market Size by Country
    • 11.3.1 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Hydroxyprogesterone Caproate Injection Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Hydroxyprogesterone Caproate Injection Market Drivers
  • 12.2 Hydroxyprogesterone Caproate Injection Market Restraints
  • 12.3 Hydroxyprogesterone Caproate Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hydroxyprogesterone Caproate Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hydroxyprogesterone Caproate Injection
  • 13.3 Hydroxyprogesterone Caproate Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hydroxyprogesterone Caproate Injection Typical Distributors
  • 14.3 Hydroxyprogesterone Caproate Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.
    According to our (Global Info Research) latest study, the global Hydroxyprogesterone Caproate Injection market size was valued at US$ 275 million in 2023 and is forecast to a readjusted size of USD 304 million by 2030 with a CAGR of 1.5% during review period.
    Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.
    This report is a detailed and comprehensive analysis for global Hydroxyprogesterone Caproate Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Hydroxyprogesterone Caproate Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Hydroxyprogesterone Caproate Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Hydroxyprogesterone Caproate Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Hydroxyprogesterone Caproate Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hydroxyprogesterone Caproate Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hydroxyprogesterone Caproate Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AMAG Pharmaceuticals, Mcguff Pharmaceuticals Inc, Aspen Oss B.V, American Regent, Inc., Mylan Institutional, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Hydroxyprogesterone Caproate Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    1 mL Injection(Including 1.1 mL)
    5 mL Injection
    Market segment by Application
    Hospitals Injection
    Clinics Injection
    Major players covered
    AMAG Pharmaceuticals
    Mcguff Pharmaceuticals Inc
    Aspen Oss B.V
    American Regent, Inc.
    Mylan Institutional
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Hydroxyprogesterone Caproate Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Hydroxyprogesterone Caproate Injection, with price, sales quantity, revenue, and global market share of Hydroxyprogesterone Caproate Injection from 2019 to 2024.
    Chapter 3, the Hydroxyprogesterone Caproate Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Hydroxyprogesterone Caproate Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Hydroxyprogesterone Caproate Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Hydroxyprogesterone Caproate Injection.
    Chapter 14 and 15, to describe Hydroxyprogesterone Caproate Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now